These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18273577)

  • 1. Antithrombotic therapy for patients with valvular heart disease.
    Vahanian A
    Herz; 2008 Feb; 33(1):44-51. PubMed ID: 18273577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recommendations for prevention of thromboembolism in heart valve diseases. Working Group on Valvular Heart Disease, European Society of Cardiology].
    Gohlke-Bärwolf C; Acar J; Oakley C; Butchart E; Burckhardt D; Delahaye JP; Horstkotte D; Bodnar E; Hall R; Kremer R
    Z Kardiol; 1995 Dec; 84(12):1018-32. PubMed ID: 8578786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic therapy in native heart valve disease.
    Völler H
    J Heart Valve Dis; 2004 May; 13(3):325-8. PubMed ID: 15222275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intracardiac thrombosis and consecutive thromboembolisms in patients with heart valve diseases: predisposition and concepts for prevention].
    Piper C; Horstkotte D
    Z Kardiol; 1998; 87 Suppl 4():1-6. PubMed ID: 9857461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intensity of oral anticoagulant therapy after heart valve replacement].
    Stenzinger W
    Z Kardiol; 1998; 87 Suppl 4():37-41. PubMed ID: 9857465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Salem DN; Stein PD; Al-Ahmad A; Bussey HI; Horstkotte D; Miller N; Pauker SG
    Chest; 2004 Sep; 126(3 Suppl):457S-482S. PubMed ID: 15383481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to define valvular atrial fibrillation?
    Fauchier L; Philippart R; Clementy N; Bourguignon T; Angoulvant D; Ivanes F; Babuty D; Bernard A
    Arch Cardiovasc Dis; 2015 Oct; 108(10):530-9. PubMed ID: 26184867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of thrombosis in heart valve diseases].
    Meyer BJ; Beer JH
    Ther Umsch; 1998 Dec; 55(12):756-61. PubMed ID: 10025189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Salem DN; O'Gara PT; Madias C; Pauker SG
    Chest; 2008 Jun; 133(6 Suppl):593S-629S. PubMed ID: 18574274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valvular heart disease in pregnancy: a review of the literature.
    Martinez-Diaz JL
    Bol Asoc Med P R; 2008; 100(4):55-9. PubMed ID: 19400530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of guideline-based anticoagulation in a patient with mitral prosthetic valve and recurrent thromboembolism.
    Mutlu H; Yerlioglu ME; Levy WK
    J Am Soc Echocardiogr; 2008 Mar; 21(3):296.e1-3. PubMed ID: 17681732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal anticoagulation therapy in patients with valvular heart disease or atrial fibrillation.
    McLeod CJ; Gersh BJ
    Arch Intern Med; 2009 Nov; 169(21):2032-3; author reply 2033. PubMed ID: 19933968
    [No Abstract]   [Full Text] [Related]  

  • 14. Adherence to American College of Cardiology/American Heart Association guidelines for the management of anticoagulation in patients with mechanical valves undergoing elective outpatient procedures.
    Kirtane AJ; Rahman AM; Martinezclark P; Jeremias A; Seto TB; Manning WJ
    Am J Cardiol; 2006 Mar; 97(6):891-3. PubMed ID: 16516596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valves.
    Chesebro JH; Adams PC; Fuster V
    J Am Coll Cardiol; 1986 Dec; 8(6 Suppl B):41B-56B. PubMed ID: 3537070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends.
    Sun JC; Davidson MJ; Lamy A; Eikelboom JW
    Lancet; 2009 Aug; 374(9689):565-76. PubMed ID: 19683642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement.
    Eitz T; Schenk S; Fritzsche D; Bairaktaris A; Wagner O; Koertke H; Koerfer R
    Ann Thorac Surg; 2008 Mar; 85(3):949-54; discussion 955. PubMed ID: 18291177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic therapy in valvular heart disease.
    Stein PD
    Clin Geriatr Med; 2001 Feb; 17(1):163-72, viii. PubMed ID: 11270129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
    Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies.
    Bryniarski L; Pelc-Nowicka A; Zabojszcz M; Mirek-Bryniarska E
    Cardiol J; 2009; 16(2):179-89. PubMed ID: 19387970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.